Ann: Botanix Raises A$10 million via Institutional Placement, page-53

Good to see cash in the bank, but let's be honest this is a poor raise given the opportunity here.

Especially considering $40 mill was raised from US biotech funds back in 2019.

It's also been stated several times that management are sick of the 'rinse and repeat' nature of the process - yet they did it anyway.

Hopefully the 9c goes to quality shareholders through Hartleys and co. The opportunity here is insane, just wish we would target and be more strategic with allocation of capital given the diutionary nature of the process.

I actually bought more in the 9's this morning, I would hope this is the last raise of this nature.